UPCOMING SESSIONS in ET
Wed, May 6, 2026
10:00 – 11:00 PM UTC
Webinar: Emerging Roles of TTR in ATTR-CM and Your Overall Health Sarah C Paciulli Click To Register
UPCOMING SESSIONS in ET
Wed, May 6, 2026 · 10:00 – 11:00 PM UTC
Webinar: Emerging Roles of TTR in ATTR-CM and Your Overall Health
Sarah C Paciulli
Click To Register
View all sessions

Light chain (AL) Amyloidosis/Primary

Amyloidosis refers to several different types of diseases where abnormal proteins are produced. These protein fibers can attach and deposit into organs, tissues,…
Cardiac amyloidosis is a restrictive cardiomyopathy that results from the deposition of misfolded light chain or transthyretin proteins, most commonly, in cardiac…
Dr. Shayna Sarosiek was an Assistant Professor of Medicine in hematology and medical oncology at Boston University School of Medicine. Dr. Sarosiek completed her…
Marina Ramirez-Alvarado is a Professor of Biochemistry and Molecular Biology at the Mayo Clinicexternal link, opens in a new tab, Rochester, Minnesota. She studies…
Assoc Prof @BUMedicine. @The_BMC hematologist. Tweeting about all things hematology and AL #Amyloidosis in particular. The J is for Jenius.
Heather J. Landau is a board-certified oncologist and hematologist, and works as part of a multidisciplinary team caring for patients with hematologic disorders.…
Eli Muchtar is a hematologist at Mayo clinic, Rochester, Minnesota. He received his medical degree from Ben Gurion University of the Negev followed by residency in…
A new staging system developed with a more accessible test to predict the chance of survival in patients living with light chain (AL) amyloidosis. Led by…